STOCK TITAN

VSee Health director Scott Metzger resigns

VSee Health, Inc. (VSEE) reported that on August 27, 2026, Scott Metzger resigned, effective immediately, from its Board of Directors and from the Board’s Compensation Committee.

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

VSee Health, Inc. (VSEE) reported that on August 27, 2026, Scott Metzger resigned, effective immediately, from its Board of Directors and from the Board’s Compensation Committee. The company states that Mr. Metzger’s resignation is not due to any disagreement regarding operations, policies, or practices.

The company’s common stock has a par value of $0.0001 per share and trades under the symbol VSEE, with warrants trading as VSEEW, each entitling the holder to purchase one share of common stock at $11.50 per whole share.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Common stock par value $0.0001 per share Par value of VSee Health, Inc. common stock
Warrant exercise price $11.50 per whole share Each warrant entitles the holder to purchase one share of common stock at this price
Resignation effective date August 27, 2026 Effective date of Scott Metzger’s resignation from the Board and Compensation Committee
Report date August 31, 2026 Date the company dated the report describing the resignation
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Compensation Committee financial
"the Compensation Committee of the Board"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
par value financial
"Common Stock, $0.0001 par value per share"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
warrants financial
"Warrants, which entitles the holder to purchase one (1) share"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

FAQ

What board change did VSEE (VSee Health, Inc.) announce on August 27, 2026?

VSee Health, Inc. announced that Scott Metzger resigned from its Board of Directors and the Board’s Compensation Committee, effective August 27, 2026. The company states that his resignation is not due to any disagreement about its operations, policies, or practices.

Did Scott Metzger resign from VSEE due to a disagreement with the company?

No. VSee Health, Inc. states that Scott Metzger’s resignation from the Board of Directors and Compensation Committee is not due to any disagreement with the company on its operations, policies, or practices.

What is the trading symbol and par value of VSee Health, Inc.’s common stock?

VSee Health, Inc.’s common stock trades under the symbol VSEE and has a par value of $0.0001 per share. The company is incorporated in Delaware and lists its principal executive offices in Boca Raton, Florida.

What are the terms of the VSEE warrants (symbol VSEEW)?

The VSee Health, Inc. warrants, trading under symbol VSEEW, each entitle the holder to purchase one share of common stock at a price of $11.50 per whole share. These warrants are listed on the OTC market.

When did VSee Health, Inc. date this board resignation report?

VSee Health, Inc. dated the report August 31, 2026, describing the resignation of Scott Metzger as having occurred on August 27, 2026 and being effective immediately on that date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001864531 0001864531 2026-08-27 2026-08-27 0001864531 VSEE:CommonStock0.0001ParValuePerShareMember 2026-08-27 2026-08-27 0001864531 VSEE:WarrantsWhichEntitlesHolderToPurchaseOne1ShareOfCommonStockAtPriceOf11.50PerWholeShareMember 2026-08-27 2026-08-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 31, 2026 (August 27, 2026)

 

VSEE HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41015   86-2970927
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

980 N Federal Hwy #304
Boca Raton, Florida
  33432
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (561) 672-7068

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class   Trading Symbol   Name of each exchange on
which registered
Common Stock, $0.0001 par value per share   VSEE   OTC
Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share   VSEEW   OTC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

  

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers

 

On August 27, 2026, Scott Metzger resigned, effective immediately, as a member of the Board of Directors (the “Board”) of VSee Health, Inc. (the “Company”) and the Compensation Committee of the Board. Mr. Metzger’s resignation is not due to any disagreement with the Company on any matter related to the Company’s operations, policies or practices.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: August 31, 2026 VSEE HEALTH, INC.
     
  By: /s/ Imoigele Aisiku
  Name:  Imoigele Aisiku
  Title: Chief Executive Officer

 

 

2

 

Filing Exhibits & Attachments

4 documents